Cargando…

Microglial autophagy in Alzheimer’s disease and Parkinson’s disease

Alzheimer’s disease (AD) and Parkinson’s disease (PD) are the most common neurodegenerative diseases, characterized by gradual and selective loss of neurons in the central nervous system. They affect more than 50 million people worldwide, and their incidence increases with age. Although most cases o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zhifu, Wang, Qi, Li, Shihua, Li, Xiao-Jiang, Yang, Weili, He, Dajian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Aging Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872664/ https://www.ncbi.nlm.nih.gov/pubmed/36704504 http://dx.doi.org/10.3389/fnagi.2022.1065183

Ejemplares similares

The role of microglial autophagy in Parkinson’s disease
por: Zhu, Rui, et al.
Publicado: (2022)

Clinical PET Imaging of Microglial Activation: Implications for Microglial Therapeutics in Alzheimer’s Disease
por: Shen, Zhiwei, et al.
Publicado: (2018)

Interaction between autophagy and the NLRP3 inflammasome in Alzheimer’s and Parkinson’s disease
por: Lu, Ranran, et al.
Publicado: (2022)

Fibroblast Growth Factor 21 Modulates Microglial Polarization That Attenuates Neurodegeneration in Mice and Cellular Models of Parkinson's Disease
por: Yang, Changwei, et al.
Publicado: (2021)

Editorial: Disease-modifying targets and strategies for Alzheimer's disease and Parkinson's disease
por: Gao, Xiaoya
Publicado: (2023)

Roles of microglial mitophagy in neurological disorders
por: Liu, Yang, et al.
Publicado: (2022)

Electro-Acupuncture Improve the Early Pattern Separation in Alzheimer’s Disease Mice via Basal Forebrain-Hippocampus Cholinergic Neural Circuit
por: Li, Long, et al.
Publicado: (2022)

Proteostasis and neurodegeneration: a closer look at autophagy in Alzheimer's disease
por: Barmaki, Haleh, et al.
Publicado: (2023)

Oculomotor impairments in de novo Parkinson’s disease
por: Zhou, Meng-Xi, et al.
Publicado: (2022)

To re-examine the intersection of microglial activation and neuroinflammation in neurodegenerative diseases from the perspective of pyroptosis
por: Li, Yuan, et al.
Publicado: (2023)

Recent Advances in Basic Research for CSF1R-Microglial Encephalopathy
por: Wang, Yan-Li, et al.
Publicado: (2021)

Efficacy and Safety of Probiotics for the Treatment of Alzheimer's Disease, Mild Cognitive Impairment, and Parkinson's Disease: A Systematic Review and Meta-Analysis
por: Xiang, Shuai, et al.
Publicado: (2022)

Alzheimer’s disease biomarkers in patients with obstructive sleep apnea hypopnea syndrome and effects of surgery: A prospective cohort study
por: Kong, Weili, et al.
Publicado: (2023)

The role of structural variations in Alzheimer’s disease and other neurodegenerative diseases
por: Wang, Hui, et al.
Publicado: (2023)

Autophagy Impairment in App Knock-in Alzheimer’s Model Mice
por: Jiang, Richeng, et al.
Publicado: (2022)

Constructing a prognostic risk model for Alzheimer’s disease based on ferroptosis
por: Wang, Xiao-Li, et al.
Publicado: (2023)

Estimated glomerular filtration rate is a biomarker of cognitive impairment in Parkinson’s disease
por: Qu, Yi, et al.
Publicado: (2023)

Structural Brain Network Abnormalities in Parkinson’s Disease With Freezing of Gait
por: Jin, Chaoyang, et al.
Publicado: (2022)

Worse Sleep Quality Aggravates the Motor and Non-Motor Symptoms in Parkinson's Disease
por: Yi, Qu, et al.
Publicado: (2022)

Potential roles of oxidative distress on neurodegeneration in Parkinson's disease with neuropsychiatric symptoms
por: Li, Dan-ning, et al.
Publicado: (2022)

Editorial: Translational Advances in Alzheimer's, Parkinson's, and Other Neurodegenerative Dementias
por: Jiang, Jiehui, et al.
Publicado: (2022)

The Association of Pre-existing Diagnoses of Alzheimer’s Disease and Parkinson’s Disease and Coronavirus Disease 2019 Infection, Severity and Mortality: Results From the Korean National Health Insurance Database
por: Kim, Ji Hee, et al.
Publicado: (2022)

Phosphorylated Tau 181 Serum Levels Predict Alzheimer’s Disease in the Preclinical Stage
por: Qin, Wei, et al.
Publicado: (2022)

Peripheral Clock System Abnormalities in Patients With Parkinson’s Disease
por: Li, Tianbai, et al.
Publicado: (2021)

Iron accumulation in the ventral tegmental area in Parkinson's disease
por: Zhang, Dongling, et al.
Publicado: (2023)

Rethinking of Alzheimer's disease: Lysosomal overloading and dietary therapy
por: Yuan, Shu, et al.
Publicado: (2023)

Validation of the European Cross-Cultural Neuropsychological Test Battery (CNTB) for the assessment of mild cognitive impairment due to Alzheimer's disease and Parkinson's disease
por: Delgado-Álvarez, Alfonso, et al.
Publicado: (2023)

Efficacy of non-pharmacological interventions for depression in individuals with Parkinson's disease: A systematic review and network meta-analysis
por: Wang, Yuxin, et al.
Publicado: (2022)

A nomogram based on iron metabolism can help identify apathy in patients with Parkinson’s disease
por: Li, Jiang-ting, et al.
Publicado: (2023)

Brain Surface Area Alterations Correlate With Gait Impairments in Parkinson’s Disease
por: Wei, Xuan, et al.
Publicado: (2022)

Progressive Prefrontal Cortex Dysfunction in Parkinson's Disease With Probable REM Sleep Behavior Disorder: A 3-Year Longitudinal Study
por: Jia, Xiuqin, et al.
Publicado: (2022)

Microglial autophagy in cerebrovascular diseases
por: Chen, Man, et al.
Publicado: (2022)

Loss of RAB39B does not alter MPTP-induced Parkinson’s disease-like phenotypes in mice
por: Wang, Zijie, et al.
Publicado: (2023)

Mendelian randomization analyses of smoking and Alzheimer’s disease in Chinese and Japanese populations
por: Zhu, Yuan, et al.
Publicado: (2023)

Analysis of gene expression profiles in Alzheimer’s disease patients with different lifespan: A bioinformatics study focusing on the disease heterogeneity
por: Zhang, Ji, et al.
Publicado: (2023)

Progressive structural and covariance connectivity abnormalities in patients with Alzheimer’s disease
por: Xiao, Yaqiong, et al.
Publicado: (2023)

Bidirectional Mendelian randomization study of psychiatric disorders and Parkinson’s disease
por: Wu, Qi, et al.
Publicado: (2023)

Research progress of ferroptosis in Parkinson’s disease: a bibliometric and visual analysis
por: Lu, Yangguang, et al.
Publicado: (2023)

The viral hypothesis in Alzheimer’s disease: SARS-CoV-2 on the cusp
por: Liu, Nanyang, et al.
Publicado: (2023)

Concomitant protein pathogenesis in Parkinson’s disease and perspective mechanisms
por: Han, Yuliang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tgo68jnnk6r1ih94cem026fqef